
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Strides to Demerge and List its Biotech Business Under Stelis Biopharma".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Strides to Demerge and List its Biotech Business Under Stelis Biopharma".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science